Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.
Press releases published on May 7, 2025
Live From Gaza: Doctors Fighting to Spare Thousands of Children From Starvation to Issue Plea in International ZOOM Call
EIN Presswire
·
May 7, 2025
Providers struggling against catastrophic conditions in northern Gaza while witnessing a child dying every 40 minutes are begging: Let the children eat! WASHINGTON (DC), DC, UNITED STATES, May 7, 2025 /EINPresswire.com/ -- In Gaza, the World Food …
CHESS Health Solutions Launches Medicaid Clinically Integrated Network to Support North Carolina Providers and Patients
GlobeNewswire
·
May 7, 2025
Winston-Salem, NC, May 07, 2025 (GLOBE NEWSWIRE) -- CHESS Health Solutions is proud to announce the launch of its Medicaid Clinically Integrated Network (CIN), a strategic model designed to help providers navigate the complexities of North Carolina’s …
Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update
GlobeNewswire
·
May 7, 2025
Total Revenues in the first quarter of 2025 reached $132.8 million, compared to $36.9 million in the same period last year, representing a 260% increase Product Revenues in the first in the first quarter of 2025 reached $109.9 million, compared to $12.4 …
Viemed Healthcare Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
LAFAYETTE, La., May 07, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its …
Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025
GlobeNewswire
·
May 7, 2025
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or …
Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025
GlobeNewswire
·
May 7, 2025
Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025 Mont-Saint-Guibert, Belgium – Wednesday May 7, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough …
Nyxoah Publiera ses Résultats Financiers du Premier Trimestre 2025 le 14 Mai 2025
GlobeNewswire
·
May 7, 2025
Nyxoah Publiera ses Résultats Financiers du Premier Trimestre 2025 le 14 Mai 2025 Mont-Saint-Guibert, Belgique – 7 mai 2025, 22h30 CET / 16h30 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société »), une société de technologie …
STERIS Declares Dividend of $0.57 per share
GlobeNewswire
·
May 7, 2025
DUBLIN, IRELAND, May 07, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on June 26, 2025, to shareholders …
Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology
GlobeNewswire
·
May 7, 2025
SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced today that JCO Precision Oncology published a real-world study suggesting that the results of …
DLH Reports Fiscal 2025 Second Quarter Results
GlobeNewswire
·
May 7, 2025
ATLANTA, May 07, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to …
Korro Reports First Quarter 2025 Financial Results and Provides Business Updates
GlobeNewswire
·
May 7, 2025
— Interim readout from Phase 1/2a REWRITE clinical trial of KRRO-110 for Alpha-1 Antitrypsin Deficiency (AATD) on track for the second half of 2025 — Streamlining operations and focusing on delivering potential value generating program milestones, with …
PainReform Launches Strategic AI Pilot with Econergy Using Its Proprietary DeepSolar™ Platform to Optimize One of Romania’s Largest Solar Projects
GlobeNewswire
·
May 7, 2025
TEL AVIV, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), today announced the launch of a strategic pilot program with Econergy Renewable Energy Ltd., a leading European independent power producer (IPP). The project will utilize …
Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 7, 2025
Catalyst Enters 2025 With Strong Momentum; Reiterates Confidence in Full-Year Outlook Delivers Record Q1 2025 Total Revenues of $141.4 Million, a 43.6% YoY Increase FIRDAPSE® and AGAMREE® Drive Sustained Organic Growth, Underscoring Execution Strength …
Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy
GlobeNewswire
·
May 7, 2025
MELBOURNE, Australia and INDIANAPOLIS, May 08, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its Fibroblast Activation Protein (FAP)-targeting therapy candidate, TLX400, has been …
Merus Announces Financial Results for the First Quarter 2025 and Provides Business Update
GlobeNewswire
·
May 7, 2025
- Petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC phase 2 trial ongoing with clinical data update at 2025 ASCO® Annual Meeting - Based on the Company’s current operating plan, existing cash, cash equivalents and marketable securities …
GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents
GlobeNewswire
·
May 7, 2025
Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); May 7, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …
GENFIT : Assemblée Générale Mixte du 17 juin 2025 — modalités de mise à disposition des documents préparatoires
GlobeNewswire
·
May 7, 2025
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 7 mai 2025 – GENFIT (Nasdaq et Euronext : GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager le …
Oncocyte to Release First Quarter 2025 Results on May 12, 2025
GlobeNewswire
·
May 7, 2025
IRVINE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first quarter 2025 financial results after the market closes on Monday, May 12, 2025. Oncocyte …
Context Therapeutics Reports First Quarter 2025 Operating and Financial Results
GlobeNewswire
·
May 7, 2025
CTIM-76 and CT-95 in Phase 1 Clinical Trials Cash and cash equivalents of $89.4 million as of March 31, 2025 Company expects its cash and cash equivalents will continue to fund operations into 2027 PHILADELPHIA, May 07, 2025 (GLOBE NEWSWIRE) -- Context …
MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance
GlobeNewswire
·
May 7, 2025
ROCKVILLE, MD, May 7, 2025 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, …